1
|
Poptsi E, Tsatali M, Agogiatou C, Bakoglidou E, Batsila G, Dellaporta D, Kounti-Zafeiropoulou F, Liapi D, Lysitsas K, Markou N, Mouzakidis C, Ouzouni F, Papasozomenou C, Soumpourou A, Vasiloglou M, Zafeiropoulos S, Tsolaki M. Longitudinal Cognitive and Physical Training Effectiveness in MCI, Based on the Experience of the Alzheimer's Hellas Day Care Centre. J Geriatr Psychiatry Neurol 2022; 35:512-526. [PMID: 34060355 DOI: 10.1177/08919887211016057] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
This study assesses the effectiveness of a multicomponent Longitudinal Cognitive Training (CT) program plus physical exercise (PE) for people with Mild Cognitive Impairment (MCI). 155 people with MCI, completed a 3 years (3Y) CT+PE, whilst 133 were control. Neuropsychological assessment was performed at baseline and 3 years later, whilst CT+PE had additional annual assessments. According to the results, the 3Y CT+PE outperformed control in cognitive abilities (p < 0.002), and Activities of Daily Living (ADL) (p < 0.001), stabilized their functional performances between 1st and 2nd year, but worsened in working and verbal memory between 2nd and 3 rd year (p < 0.002). Control deteriorated in cognitive functions (p < 0.001) and ADL (p < 0.001) after 3 years, whilst 1.33% of the experimental and 13.53% of the control group progressed to dementia (p < 0.001). Longitudinal CT+PE improves cognitive performance and ADL in MCI and delay the progression to dementia.
Collapse
Affiliation(s)
- Eleni Poptsi
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece.,Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Marianna Tsatali
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece.,University of Sheffield International Faculty, City College, Thessaloniki, Greece
| | - Christina Agogiatou
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Evaggelia Bakoglidou
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Georgia Batsila
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Dionysia Dellaporta
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | | | - Despoina Liapi
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Konstantinos Lysitsas
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Nefeli Markou
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Christos Mouzakidis
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Fani Ouzouni
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Chrysa Papasozomenou
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Aikaterini Soumpourou
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Maria Vasiloglou
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Stavros Zafeiropoulos
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Magda Tsolaki
- Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece.,Aristotle University of Thessaloniki, Thessaloniki, Greece
| |
Collapse
|
2
|
Lazarou I, Moraitou D, Papatheodorou M, Vavouras I, Lokantidou C, Agogiatou C, Gialaoutzis M, Nikolopoulos S, Stavropoulos TG, Kompatsiaris I, Tsolaki M. Adaptation and Validation of the Memory Alteration Test (M@T) in Greek Middle-Aged, Older, and Older-Old Population with Subjective Cognitive Decline and Mild Cognitive Impairment. J Alzheimers Dis 2021; 84:1219-1232. [PMID: 34657882 DOI: 10.3233/jad-210558] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
BACKGROUND The Memory Alteration Test (M@T) is a verbal episodic and semantic memory screening test able to detect subjective cognitive decline (SCD) and Mild Cognitive Impairment (MCI). OBJECTIVE To adapt M@T, creating a Greek version of the Memory Alteration Test (M@T-GR), and to validate M@T-GR compared to the Mini-Mental State Examination (MMSE), and Subjective Cognitive Decline- Questionnaire (SCD-Q) MyCog and TheirCog. METHODS 232 people over 55 years old participated in the study and they were classified as healthy controls (HC, n = 65), SCD (n = 78), or MCI (n = 89). RESULTS The ANCOVA showed that the M@T-GR's total score was significantly different in HC and SCD (I-J = 2.26, p = 0.032), HC and MCI (I-J = 6.16, p < 0.0001), and SCD compared to MCI (I-J = 3.90, p < 0.0001). In particular, a cut-off score of 46.50 points had an 81%sensitivity and 61%specificity for discriminating HC from SCD (AUC = 0.76, p < 0.0001), while a cut-off score of 45.50 had a sensitivity of 92%and a specificity of 73%for discriminating MCI (AUC = 0.88, p < 0.0001), and a cut-off score of 45.50 points had a sensitivity of 63%and a specificity of 73%for discriminating SCD from those with MCI (AUC = 0.69, p < 0.0021). Exploratory factor analysis indicated that there was one factor explaining 38.46%of the total variance. Internal consistency was adequate (α= 0.75), while convergent validity was found between M@T-GR and MMSE (r = 0.37, p < 0.0001) and SCD-Q TheirCog (r = -0.32, p < 0.0001). CONCLUSION The M@T-GR is a good to fair screening tool with adequate discriminant validity for administration in people with SCD and MCI in Greece.
Collapse
Affiliation(s)
- Ioulietta Lazarou
- Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece.,1st Department of Neurology, G.H. "AHEPA", School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Despina Moraitou
- Laboratory of Psychology, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Marianna Papatheodorou
- Greek Association of Alzheimer's Disease and Related Disorders (GAADRD), Thessaloniki, Greece
| | - Isaak Vavouras
- Greek Association of Alzheimer's Disease and Related Disorders (GAADRD), Thessaloniki, Greece
| | - Chrysanthi Lokantidou
- Greek Association of Alzheimer's Disease and Related Disorders (GAADRD), Thessaloniki, Greece
| | - Christina Agogiatou
- Greek Association of Alzheimer's Disease and Related Disorders (GAADRD), Thessaloniki, Greece
| | - Moses Gialaoutzis
- Greek Association of Alzheimer's Disease and Related Disorders (GAADRD), Thessaloniki, Greece
| | - Spiros Nikolopoulos
- Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece
| | - Thanos G Stavropoulos
- Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece
| | - Ioannis Kompatsiaris
- Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece
| | - Magda Tsolaki
- Information Technologies Institute, Centre for Research and Technology Hellas, Thessaloniki, Greece.,1st Department of Neurology, G.H. "AHEPA", School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.,Greek Association of Alzheimer's Disease and Related Disorders (GAADRD), Thessaloniki, Greece
| |
Collapse
|
3
|
Tsatali M, Moraitou D, Poptsi E, Sia E, Agogiatou C, Gialaouzidis M, Tabakis IM, Avdikou K, Bakoglidou E, Batsila G, Bekiaridis-Moschou D, Chatziroumpi O, Diamantidou A, Gavra A, Kouroundi E, Liapi D, Markou N, Ouzouni F, Papasozomenou C, Soumpourou A, Tsolaki M. Are There Any Cognitive and Behavioral Changes Potentially Related to Quarantine Due to the COVID-19 Pandemic in People with Mild Cognitive Impairment and AD Dementia? A Longitudinal Study. Brain Sci 2021; 11:brainsci11091165. [PMID: 34573186 PMCID: PMC8472805 DOI: 10.3390/brainsci11091165] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2021] [Revised: 08/26/2021] [Accepted: 08/30/2021] [Indexed: 01/05/2023] Open
Abstract
The aim of the study was to examine potential cognitive, mood (depression and anxiety) and behavioral changes that may be related to the quarantine and the lockdown applied during the COVID-19 pandemic in Greek older adults with mild cognitive impairment (MCI), and AD dementia in mild and moderate stages. Method: 407 older adults, diagnosed either with MCI or AD dementia (ADD), were recruited from the Day Centers of the Greek Association of Alzheimer Disease and Related Disorders (GAADRD). Neuropsychological assessment was performed at baseline (at the time of diagnosis) between May and July of 2018, as well as for two consecutive follow-up assessments, identical in period, in 2019 and 2020. The majority of participants had participated in non-pharmacological interventions during 2018 as well as 2019, whereas all of them continued their participation online in 2020. Results: Mixed measures analysis of variance showed that participants’ ‘deterioration difference—D’ by means of their performance difference in neuropsychological assessments between 2018–2019 (D1) and 2019–2020 (D2) did not change, except for the FUCAS, RAVLT, and phonemic fluency tests, since both groups resulted in a larger deterioration difference (D2) in these tests. Additionally, three path models examining the direct relationships between performance in tests measuring mood, as well as everyday functioning and cognitive measures, showed that participants’ worsened performance in the 2019 and 2020 assessments was strongly affected by NPI performance, in sharp contrast to the 2018 assessment. Discussion: During the lockdown period, MCI and ADD patients’ neuropsychological performance did not change, except from the tests measuring verbal memory, learning, and phonemic fluency, as well as everyday functioning. However, the natural progression of the MCI as well as ADD condition is the main reason for participants’ deterioration. Mood performance became increasingly closely related to cognition and everyday functioning. Hence, the role of quarantine and AD progression are discussed as potential factors associated with impairments.
Collapse
Affiliation(s)
- Marianna Tsatali
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
- Laboratory of Neurodegenerative Diseases, Center for Interdisciplinary Research and Innovation (CIRI-AUTh) Balkan Center, Buildings A & B, Aristotle University of Thessaloniki, 57001 Thessaloni, Greece
- Correspondence:
| | - Despina Moraitou
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
- Laboratory of Neurodegenerative Diseases, Center for Interdisciplinary Research and Innovation (CIRI-AUTh) Balkan Center, Buildings A & B, Aristotle University of Thessaloniki, 57001 Thessaloni, Greece
- Lab of Psychology, Section of Experimental & Cognitive Psychology, School of Psychology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
| | - Eleni Poptsi
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
- Laboratory of Neurodegenerative Diseases, Center for Interdisciplinary Research and Innovation (CIRI-AUTh) Balkan Center, Buildings A & B, Aristotle University of Thessaloniki, 57001 Thessaloni, Greece
- Lab of Psychology, Section of Experimental & Cognitive Psychology, School of Psychology, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
| | - Eleni Sia
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Christina Agogiatou
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Moses Gialaouzidis
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Irene-Maria Tabakis
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Konstantina Avdikou
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Evaggelia Bakoglidou
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Georgia Batsila
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Dimitrios Bekiaridis-Moschou
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Ourania Chatziroumpi
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Alexandra Diamantidou
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Andromachi Gavra
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Eleni Kouroundi
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Despina Liapi
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Nefeli Markou
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Fani Ouzouni
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Chrysa Papasozomenou
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Aikaterini Soumpourou
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
| | - Magdalini Tsolaki
- Greek Association of Alzheimer’s Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (D.M.); (E.P.); (E.S.); (C.A.); (M.G.); (I.-M.T.); (K.A.); (E.B.); (G.B.); (D.B.-M.); (O.C.); (A.D.); (A.G.); (E.K.); (D.L.); (N.M.); (F.O.); (C.P.); (A.S.); (M.T.)
- Laboratory of Neurodegenerative Diseases, Center for Interdisciplinary Research and Innovation (CIRI-AUTh) Balkan Center, Buildings A & B, Aristotle University of Thessaloniki, 57001 Thessaloni, Greece
- 1st Department of Neurology, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece
| |
Collapse
|
4
|
Tsatali M, Poptsi E, Moraitou D, Agogiatou C, Bakoglidou E, Gialaouzidis M, Papasozomenou C, Soumpourou A, Tsolaki M. Discriminant Validity of the WAIS-R Digit Symbol Substitution Test in Subjective Cognitive Decline, Mild Cognitive Impairment (Amnestic Subtype) and Alzheimer's Disease Dementia (ADD) in Greece. Brain Sci 2021; 11:brainsci11070881. [PMID: 34209189 PMCID: PMC8301784 DOI: 10.3390/brainsci11070881] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2021] [Revised: 06/24/2021] [Accepted: 06/28/2021] [Indexed: 12/14/2022] Open
Abstract
Objective: The aim of the current study was to estimate the discriminant potential and validity of the Digit Symbol Substitution Test (DSST) of the WAIS-R in the Greek elderly population meeting criteria for subjective cognitive decline (SCD), mild cognitive impairment (aMCI; amnestic subtype), or Alzheimer’s disease dementia (ADD). Method: Four hundred eighty-eight community-dwelling older adults, visitors of the Day Center of Alzheimer Hellas, participated in the study. Two hundred forty-three of them met the criteria for ADD, one hundred eighty-two for aMCI and sixty-three for SCD. Results: Path analysis indicated that the DSST score is affected by age group, educational level, and diagnostic category, but is not affected by gender. The ROC curve analysis showed that the DSST sum score could perfectly differentiate SCD from ADD patients, whereas test’s discriminant potential between aMCI and dementia ADD’s subtype was satisfactory. However, DSST was unable to separate the SCD from the aMCI group. Conclusion: It appears that the DSST is unable to separate the SCD from aMCI population. Therefore, the test in question may be insensitive to incipient cognitive decline. On the contrary, the discriminant potential of the DSST as regards SCD and ADD is excellent, while discrimination between aMCI and ADD is good.
Collapse
Affiliation(s)
- Marianna Tsatali
- Department of Psychology, Greek Association of Alzheimer Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (E.P.); (D.M.); (C.A.); (E.B.); (M.G.); (C.P.); (A.S.); (M.T.)
- Correspondence:
| | - Eleni Poptsi
- Department of Psychology, Greek Association of Alzheimer Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (E.P.); (D.M.); (C.A.); (E.B.); (M.G.); (C.P.); (A.S.); (M.T.)
- Laboratory of Psychology, Section of Cognitive and Experimental Psychology, School of Psychology, Aristotle University of Thessaloniki (AUTh), 54124 Thessaloniki, Greece
| | - Despina Moraitou
- Department of Psychology, Greek Association of Alzheimer Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (E.P.); (D.M.); (C.A.); (E.B.); (M.G.); (C.P.); (A.S.); (M.T.)
- Laboratory of Psychology, Section of Cognitive and Experimental Psychology, School of Psychology, Aristotle University of Thessaloniki (AUTh), 54124 Thessaloniki, Greece
- Center for Interdisciplinary Research and Innovation, Laboratory of Neurodegenerative Diseases, Aristotle University of Thessaloniki (CIRI-AUTh), 57001 Thessaloniki, Greece
| | - Christina Agogiatou
- Department of Psychology, Greek Association of Alzheimer Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (E.P.); (D.M.); (C.A.); (E.B.); (M.G.); (C.P.); (A.S.); (M.T.)
| | - Evaggelia Bakoglidou
- Department of Psychology, Greek Association of Alzheimer Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (E.P.); (D.M.); (C.A.); (E.B.); (M.G.); (C.P.); (A.S.); (M.T.)
| | - Moses Gialaouzidis
- Department of Psychology, Greek Association of Alzheimer Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (E.P.); (D.M.); (C.A.); (E.B.); (M.G.); (C.P.); (A.S.); (M.T.)
| | - Chrysa Papasozomenou
- Department of Psychology, Greek Association of Alzheimer Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (E.P.); (D.M.); (C.A.); (E.B.); (M.G.); (C.P.); (A.S.); (M.T.)
| | - Aikaterini Soumpourou
- Department of Psychology, Greek Association of Alzheimer Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (E.P.); (D.M.); (C.A.); (E.B.); (M.G.); (C.P.); (A.S.); (M.T.)
| | - Magdalini Tsolaki
- Department of Psychology, Greek Association of Alzheimer Disease and Related Disorders (GAADRD), 54643 Thessaloniki, Greece; (E.P.); (D.M.); (C.A.); (E.B.); (M.G.); (C.P.); (A.S.); (M.T.)
- Center for Interdisciplinary Research and Innovation, Laboratory of Neurodegenerative Diseases, Aristotle University of Thessaloniki (CIRI-AUTh), 57001 Thessaloniki, Greece
| |
Collapse
|
5
|
Poptsi E, Moraitou D, Eleftheriou M, Kounti-Zafeiropoulou F, Papasozomenou C, Agogiatou C, Bakoglidou E, Batsila G, Liapi D, Markou N, Nikolaidou E, Ouzouni F, Soumpourou A, Vasiloglou M, Tsolaki M. Normative Data for the Montreal Cognitive Assessment in Greek Older Adults With Subjective Cognitive Decline, Mild Cognitive Impairment and Dementia. J Geriatr Psychiatry Neurol 2019; 32:265-274. [PMID: 31159629 DOI: 10.1177/0891988719853046] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
OBJECTIVE The aim of the study was to provide normative data for the MoCA in a Greek cohort of people older than 60 years who meet criteria for subjective cognitive decline (SCD), mild cognitive impairment (MCI), or dementia in order to optimize cutoff scores for each diagnostic group. METHOD Seven hundred forty-six community-dwelling older adults, visitors of the Day Center of Alzheimer Hellas were randomly chosen. Three hundred seventy-nine of them met the criteria for dementia, 245 for MCI and 122 for SCD. RESULTS Initial statistical analyses showed that the total MoCA score is not affected by gender (P = .164), or age (P = .144) but is affected by educational level (P < .001). A cutoff score of 23 for low educational level (≤6 years) can distinguish people with SCD from MCI (sensitivity 71.4%, specificity 84.2%), while 26 is the cutoff score for middle educational level (7-12 years; sensitivity 73.2%, specificity 67.0%) and high educational level (≥13 years; sensitivity 77.6%, specificity 74.7%). Montreal Cognitive Assessment can discriminate older adults with SCD from dementia, with a cutoff score of 20 for low educational level (sensitivity 100%, specificity 92.3%) and a cutoff score 23 for middle educational level (sensitivity 97.6%, specificity 92.7%) and high educational level (sensitivity 98.5%, specificity 100%). CONCLUSION Montreal Cognitive Assessment is not affected by age or gender but is affected by the educational level. The discriminant potential of MoCA between SCD and MCI is good, while the discrimination of SCD from dementia is excellent.
Collapse
Affiliation(s)
- Eleni Poptsi
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece.,2 Laboratory of Psychology, Section of Cognitive and Experimental Psychology, School of Psychology, Aristotle University of Thessaloniki (AUTh), Thessaloniki, Greece
| | - Despina Moraitou
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece.,2 Laboratory of Psychology, Section of Cognitive and Experimental Psychology, School of Psychology, Aristotle University of Thessaloniki (AUTh), Thessaloniki, Greece
| | - Marina Eleftheriou
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | | | - Chrysa Papasozomenou
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Christina Agogiatou
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Evaggelia Bakoglidou
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Georgia Batsila
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Despina Liapi
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Nefeli Markou
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Evdokia Nikolaidou
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Fani Ouzouni
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Aikaterini Soumpourou
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Maria Vasiloglou
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece
| | - Magda Tsolaki
- 1 Greek Association of Alzheimer's Disease and Related Disorders, Thessaloniki, Greece.,4 1st Department of Neurology, Medical School, Aristotle University of Thessaloniki (AUTh), Thessaloniki, Greece
| |
Collapse
|
6
|
Tsolaki M, Kounti F, Agogiatou C, Poptsi E, Bakoglidou E, Zafeiropoulou M, Soumbourou A, Nikolaidou E, Batsila G, Siambani A, Nakou S, Mouzakidis C, Tsiakiri A, Zafeiropoulos S, Karagiozi K, Messini C, Diamantidou A, Vasiloglou M. Effectiveness of nonpharmacological approaches in patients with mild cognitive impairment. NEURODEGENER DIS 2010; 8:138-45. [PMID: 21135531 DOI: 10.1159/000320575] [Citation(s) in RCA: 61] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2009] [Accepted: 08/20/2010] [Indexed: 11/19/2022] Open
Abstract
BACKGROUND Mild cognitive impairment (MCI) patients are at increased risk of developing dementia. There is a conflict if cognitive interventions can improve cognitive and functional performances in order to delay the development of dementia. OBJECTIVES This study aimed to examine the effectiveness of a holistic cognitive rehabilitation program on patients with MCI. METHODS The participants, 176 MCI patients with Mini-Mental State Examination = 27.89 (1.73), were classified into 2 groups matched for age, gender, education and cognitive abilities: (1) patients (104) on nonpharmacological therapy and (2) patients (72) on no therapy at all. The effectiveness of the interventions was assessed by neuropsychological evaluation performed at baseline and at the end of the interventions. RESULTS Between-group difference in benefit of the experimental group was demonstrated in abilities of executive function (p = 0.004), verbal memory (p = 0.003), praxis (p ≤ 0.012), daily function (p = 0.001) and general cognitive ability (p ≤ 0.005). The experimental patients improved cognitive and functional performances, while the control patients demonstrated deterioration in daily function (p = 0.004). CONCLUSIONS Our findings indicate that nonpharmacological therapy of the holistic approach can improve MCI patients' cognitive and functional performances.
Collapse
Affiliation(s)
- Magda Tsolaki
- Greek Alzheimer Association, Aristotle University, Thessaloniki, Greece.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Tsolaki M, Kounti F, Agogiatou C. F2‐01‐04: Effectiveness of pharmacological and non pharmacological therapy in patients with MCI and Mild Alzheimer's disease. Alzheimers Dement 2009. [DOI: 10.1016/j.jalz.2009.05.305] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Magdalini Tsolaki
- Greek Alzheimer AssociationThessalonikiGreece
- Aristotle University of ThessalonikiThessalonikiGreece
| | | | | |
Collapse
|